In these combined RT and SIRPα-CD47 checkpoint inhibition treatments, through quantification of enhanced immunogenic activities and ICD, we demonstrate that the primary role of macrophages is the induction of a systemic immune response and the promotion of T cell cytotoxicity that produces additional ICD, not direct tumor killing. Here, CD47 is linked to neoplasm.